Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Stocks search for momentum as investors brace for more Fed tightening
06:39pm, Monday, 19'th Sep 2022 MarketWatch
U.S. stocks flip between gains and losses Monday as investors brace for more Federal Reserve interest-rate tightening later this week.
Vaccine Stocks: Down but Not Out?
06:29pm, Monday, 19'th Sep 2022
Whether the pandemic is over or not, plenty of people are still looking for protection against COVID-19.
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
02:47pm, Monday, 19'th Sep 2022
It's a mixed day for the stock market, but it's not a good day for vaccine stocks. Across the board, these names are getting sold.
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
01:35pm, Monday, 19'th Sep 2022
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. But the pandemic is over," Biden said.
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
11:31am, Monday, 19'th Sep 2022
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with "60 Minutes" that aired on Sunday. Moderna Inc. MRNA, -9.41% fell
Why BioNTech, Moderna And Novavax Shares Are Diving - Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX)
11:03am, Monday, 19'th Sep 2022
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo
Pharma Stock Roundup: J&J New Buyback Plan, CHMP Nod to PFE's BA.4, BA.5 Omicron Jab
02:39pm, Friday, 16'th Sep 2022 Zacks Investment Research
J&J (JNJ) announces a new $5 billion stock buyback plan. CHMP recommends authorizing Pfizer's (PFE) Omicron BA.4 and BA.5 boosters in Europe.
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für die Umwandlung der bedingten Marktzulassung von COMIRNATY® in eine vollständige Marktzulassung in der Europäischen Union
12:00pm, Friday, 16'th Sep 2022 GlobeNewswire Inc.
NEW YORK und MAINZ, Deutschland, 16. September 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimit
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
12:00pm, Friday, 16'th Sep 2022 GlobeNewswire Inc.
NEW YORK and MAINZ, GERMANY, September 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea
Pfizer, BioNTech COVID vaccine gets CHMP recommendation for 'full' MA for all indications
08:37am, Friday, 16'th Sep 2022
Pfizer Inc. PFE, -0.46% and BioNTech SE BNTX, -1.64% said Friday that the Committee for Medicinal Products for Human Use (CHMP) for the European Medicines Agency (EMA) has recommended the companies' C
Pfizer (PFE) Starts Late-Stage Study on Influenza Vaccine
03:54pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Pfizer (PFE) doses the first participants in the phase III study of its investigational mRNA-based influenza vaccine. The study will enroll nearly 25,000 participants.
U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
06:50pm, Tuesday, 13'th Sep 2022 MarketWatch
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the numbers need to be viewed gently, given the number of people testing at home, where t
Pfizer (PFE), BioNTech Omicron BA.4, BA.5 Boosters Get CHMP Nod
04:05pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech (BNTX) get a positive recommendation from CHMP for Omicron BA.4 and BA.5-adapted bivalent vaccines.
Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults
03:20pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Novavax (NVAX) gets authorization from the European Union to use its COVID-19 vaccine as a booster dose in adults.
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für Auffrischungsimpfung mit an Omikron BA.4/BA.5-angepassten bivalenten COVID-19-Impfstoff in der Europäischen Union
03:20pm, Monday, 12'th Sep 2022 GlobeNewswire Inc.
NEW YORK und MAINZ, Deutschland, 12. September 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer”) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) gaben heute bekannt, dass der Ausschuss für Humanarzneimit
